CorMedix | 4: Statement of changes in beneficial ownership of securities-Officer Mistry Erin
CorMedix | 8-K: Current report
CorMedix | 4: Statement of changes in beneficial ownership of securities-Officer Hurlburt Elizabeth
CorMedix | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nomura Holdings, Inc.(0.3%),Nomura Securities International, Inc.(0.3%)
CorMedix | 144: Notice of proposed sale of securities pursuant to Rule 144
CorMedix | 10-Q: Q3 2024 Earnings Report
CorMedix | 8-K: CorMedix Inc. Reports THIRD Quarter AND NINE MONTH 2024 Financial Results and Provides Business Update
CorMedix | DEF 14A: Definitive information statements
CorMedix | 10-Q: Q2 2024 Earnings Report
CorMedix | 8-K: CorMedix Inc. Reports SECOND Quarter AND SIX MONTH 2024 Financial Results and Provides Business Update
CorMedix | EFFECT: Others
CorMedix | CORRESP: CORRESP
CorMedix | UPLOAD: Others
CorMedix | 4: Statement of changes in beneficial ownership of securities-Officer Todisco Joseph
CorMedix | S-3: Registration statement for specified transactions by certain issuers
CorMedix | 10-Q: Q1 2024 Earnings Report
CorMedix | 8-K: CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
CorMedix | 4: Statement of changes in beneficial ownership of securities-Director Lefkowitz Steven W
CorMedix | 4: Statement of changes in beneficial ownership of securities-Director Dillione Janet
CorMedix | 4: Statement of changes in beneficial ownership of securities-Director Kaplan Myron